A Study of FRaDCs for Ovarian Cancer
Conditions: Fallopian Tube Carcinosarcoma; Primary Peritoneal Carcinosarcoma; Recurrent Fallopian Tube Carcinoma; Recurrent Fallopian Tube Clear Cell Adenocarcinoma; Recurrent Fallopian Tube Endometrioid Adenocarcinoma; Recurrent Fallopian Tube High Grade Serous Adenocarcinoma; Recu rrent Ovarian Carcinoma; Recurrent Ovarian Carcinosarcoma; Recurrent Ovarian Clear Cell Adenocarcinoma; Recurrent Ovarian Endometrioid Adenocarcinoma; Recurrent Ovarian High Grade Serous Adenocarcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Primary Periton eal Clear Cell Ad...
Source: ClinicalTrials.gov - June 27, 2023 Category: Research Source Type: clinical trials
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Conditions: Advanced Solid Tumor; High Grade Serous Adenocarcinoma of Ovary; Squamous Non-small-cell Lung Cancer; Triple Negative Breast Cancer; Gastric Adenocarcinoma; Colorectal Adenocarcinoma; Esophageal Squamous Cell Carcinoma; Esophageal Adenocarcinoma; Gastro esophageal Junction Adenocarcinoma; Transitional Cell Carcinoma of Bladder; Head and Neck Squamous Cell Carcinoma; Ovarian Carcinosarcoma; Uterine Carcinosarcoma; Uterine Serous Carcinoma; Endometrium Cancer; Chromosomal Instability Intervention: Drug: VLS-1488 Sponsor: Vo...
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials
